Interesting ImagesFDG Hepatic Superscan Due to Metastatic Infiltration of Prostate CancerYildirim, Nilufer MD*; Dede, Didem Sener MD†; Gumuskaya, Berrak MD‡Author Information From the Departments of *Nuclear Medicine †Oncology ‡Pathology, Ankara Yildirim Beyazit University, Affiliated Ankara City Hospital, Bilkent Integrated Health Campus, Cankaya, Ankara, Turkey. Received for publication January 4, 2020; revision accepted February 24, 2020. Conflicts of interest and sources of funding: none declared. Correspondence to: Nilufer Yildirim, MD, Ankara Yildirim Beyazit University, Affiliated Ankara City Hospital, Bilkent Integrated Health Campus, 06800, Cankaya, Ankara, Turkey. E-mail: email@example.com. Clinical Nuclear Medicine: June 2020 - Volume 45 - Issue 6 - p 474-476 doi: 10.1097/RLU.0000000000003044 Buy Metrics Abstract A 69-year-old man with prostate cancer presented to the hospital with 2 weeks’ history of fever, abdominal distension, and fatigue. Laboratory findings showed signs of acute liver failure, and marked elevation of lactate dehydrogenase and tumor marker levels. Abdominal CT showed hepatomegaly with multiple hypodense lesions in both lobes, suggesting metastases. FDG PET/CT scan shows hypermetabolism unusually in the liver with significantly suppressed heart and brain activity, reminiscent of an FDG hepatic superscan. The hypermetabolic lesions confirmed with Tru-Cut needle biopsy of the liver as metastasis of prostate cancer. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.